Loading events
19 Jun
Discovery and preclinical investigation of th...
Discovery and preclinical investigation of the first Type II inhibitor of the SRC kinase. /events/discovery-and-preclinical-investigation-first-type-ii-inhibitor-src-kinaseMain Lecture Hall - Salón de Actos
Asier Unciti-Broceta
FRSC. Personal Chair of Medicinal Chemistry and Head of the Innovative Therapeutics Lab. Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh.
}
Discovery and preclinical investigation of th...
Discovery and preclinical investigation of the first Type II inhibitor of the SRC kinase. /es/events/discovery-and-preclinical-investigation-first-type-ii-inhibitor-src-kinase-0Main Lecture Hall - Salón de Actos
Asier Unciti-Broceta
FRSC. Personal Chair of Medicinal Chemistry and Head of the Innovative Therapeutics Lab. Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, The University of Edinburgh.
}
Specific integrin-mechanosignaling role in sm...
Specific integrin-mechanosignaling role in small RhoGTPases activation and cancer /events/specific-integrin-mechanosignaling-role-small-rhogtpases-activation-and-cancerDra. Georgina Coló
Instituto de Investigaciones Bioquímicas
INIBIBB-CONICET-UNS
Bahía Blanca, Argentina
}